{"id":"https://openalex.org/W3214336348","doi":"https://doi.org/10.1182/blood-2021-149849","title":"A Phase II, Randomized, Multicenter, Open-Label Study Evaluating the Effect of Crizanlizumab and Standard of Care (SoC) Versus Standard of Care Alone on Renal Function in Patients with Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)","display_name":"A Phase II, Randomized, Multicenter, Open-Label Study Evaluating the Effect of Crizanlizumab and Standard of Care (SoC) Versus Standard of Care Alone on Renal Function in Patients with Chronic Kidney Disease Due to Sickle Cell Nephropathy (STEADFAST)","publication_year":2021,"publication_date":"2021-11-05","ids":{"openalex":"https://openalex.org/W3214336348","doi":"https://doi.org/10.1182/blood-2021-149849","mag":"3214336348"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2021-149849","doi":"https://doi.org/10.1182/blood-2021-149849","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-149849","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://nottingham-repository.worktribe.com/output/49829967","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030174386","display_name":"Santosh L. Saraf","orcid":"https://orcid.org/0000-0002-8584-4194","observed_orcids":["https://orcid.org/0000-0002-8584-4194"]},"institutions":[{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Santosh L. Saraf","raw_affiliation_strings":["Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Sickle Cell Center, Section of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL","institution_ids":["https://openalex.org/I39422238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046199747","display_name":"Kenneth I. Ataga","orcid":"https://orcid.org/0000-0002-4501-9982","observed_orcids":["https://orcid.org/0000-0002-4501-9982"]},"institutions":[{"id":"https://openalex.org/I160606119","display_name":"University of Tennessee Health Science Center","ror":"https://ror.org/0011qv509","country_code":"US","type":"education","lineage":["https://openalex.org/I160606119"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth I. Ataga","raw_affiliation_strings":["UTHSC Center for Sickle Cell Disease, Memphis, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UTHSC Center for Sickle Cell Disease, Memphis, TN","institution_ids":["https://openalex.org/I160606119"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075327487","display_name":"Vimal Kumar Derebail","orcid":"https://orcid.org/0000-0002-7662-7497","observed_orcids":["https://orcid.org/0000-0002-7662-7497"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I1333535994","display_name":"University of North Carolina Health Care","ror":"https://ror.org/00qz24g20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1333535994"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vimal K. Derebail","raw_affiliation_strings":["UNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I1333535994"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044179446","display_name":"Claire C. Sharpe","orcid":"https://orcid.org/0000-0003-1704-8492","observed_orcids":["https://orcid.org/0000-0003-1704-8492"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Claire C. Sharpe","raw_affiliation_strings":["Renal Sciences, Department of Inflammation Biology, King's College London, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Renal Sciences, Department of Inflammation Biology, King's College London, London, United Kingdom","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021368239","display_name":"Adlette C. Inati","orcid":"https://orcid.org/0000-0002-9187-5974","observed_orcids":["https://orcid.org/0000-0002-9187-5974"]},"institutions":[{"id":"https://openalex.org/I4210134894","display_name":"Nini Hospital","ror":"https://ror.org/0359v5r48","country_code":"LB","type":"healthcare","lineage":["https://openalex.org/I4210134894"]},{"id":"https://openalex.org/I56306041","display_name":"Lebanese American University","ror":"https://ror.org/00hqkan37","country_code":"LB","type":"education","lineage":["https://openalex.org/I56306041"]}],"countries":["LB"],"is_corresponding":false,"raw_author_name":"Adlette Inati","raw_affiliation_strings":["Division of Pediatric Hematology and Oncology, Nini Hospital, Tripoli, Lebanon","Lebanese American University, School of Medicine, Byblos, Lebanon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Hematology and Oncology, Nini Hospital, Tripoli, Lebanon","institution_ids":["https://openalex.org/I4210134894"]},{"raw_affiliation_string":"Lebanese American University, School of Medicine, Byblos, Lebanon","institution_ids":["https://openalex.org/I56306041"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087478223","display_name":"Jeffrey D. Lebensburger","orcid":"https://orcid.org/0000-0001-5011-1022","observed_orcids":["https://orcid.org/0000-0001-5011-1022"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey D. Lebensburger","raw_affiliation_strings":["Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085748553","display_name":"Laurie DeBonnett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laurie DeBonnett","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100376923","display_name":"Yifan Zhang","orcid":"https://orcid.org/0000-0001-8145-1054","observed_orcids":["https://orcid.org/0000-0001-8145-1054"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yifan Zhang","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041859157","display_name":"Pablo Bartolucci","orcid":"https://orcid.org/0000-0002-7007-1344","observed_orcids":["https://orcid.org/0000-0002-7007-1344"]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210130325","display_name":"H\u00f4pitaux Universitaires Henri-Mondor","ror":"https://ror.org/033yb0967","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210130325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pablo Bartolucci","raw_affiliation_strings":["Service de M\u00e9decine Interne, H\u00f4pital Henri-Mondor, Assistance Publique-H\u00f4pitaux de Paris, Universit\u00e9 Paris 12, Cr\u00e9teil, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service de M\u00e9decine Interne, H\u00f4pital Henri-Mondor, Assistance Publique-H\u00f4pitaux de Paris, Universit\u00e9 Paris 12, Cr\u00e9teil, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210130325"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"Supplement 1","first_page":"3096","last_page":"3096"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11534","display_name":"Erythropoietin and Anemia Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crizanlizumab","display_name":"crizanlizumab","score":0.925000011920929},{"id":"https://openalex.org/keywords/sickle-cell-nephropathy","display_name":"sickle cell nephropathy","score":0.9229999780654907},{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.9229999780654907},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9810000061988831},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.7250000238418579},{"id":"https://openalex.org/keywords/albuminuria","display_name":"albuminuria","score":0.8429999947547913},{"id":"https://openalex.org/keywords/endothelin-1","display_name":"endothelin-1","score":0.8889999985694885},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.9079999923706055},{"id":"https://openalex.org/keywords/vessel-occlusion","display_name":"vascular occlusion","score":0.8519999980926514},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.7850000262260437},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.6890000104904175},{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.8240000009536743},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.7770000100135803},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.9259999990463257},{"id":"https://openalex.org/keywords/renal-ischemia-reperfusion-injury","display_name":"renal ischemia-reperfusion injury","score":0.7080000042915344},{"id":"https://openalex.org/keywords/albumin-creatinine-ratio","display_name":"albumin-creatinine ratio","score":0.7049999833106995}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8977787494659424},{"id":"https://openalex.org/C2776174234","wikidata":"https://www.wikidata.org/wiki/Q974792","display_name":"Albuminuria","level":3,"score":0.796215295791626},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.729808509349823},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.6892327070236206},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5561455488204956},{"id":"https://openalex.org/C2780472472","wikidata":"https://www.wikidata.org/wiki/Q424337","display_name":"Acute kidney injury","level":2,"score":0.5497784614562988},{"id":"https://openalex.org/C2780306776","wikidata":"https://www.wikidata.org/wiki/Q426660","display_name":"Creatinine","level":2,"score":0.45065686106681824},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.41326600313186646},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.36818382143974304},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33390164375305176}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1182/blood-2021-149849","doi":"https://doi.org/10.1182/blood-2021-149849","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2021-149849","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:oai:https://nottingham-repository.worktribe.com/:49829967","doi":null,"is_oa":true,"landing_page_url":"https://nottingham-repository.worktribe.com/output/49829967","pdf_url":null,"source":{"id":"https://openalex.org/S4306402483","display_name":"Repository@Nottingham (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:oai:nottingham-repository.worktribe.com:49829967","doi":null,"is_oa":false,"landing_page_url":"https://doi.org/10.1182/BLOOD-2021-149849","pdf_url":null,"source":{"id":"https://openalex.org/S4306402483","display_name":"Repository@Nottingham (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:https://nottingham-repository.worktribe.com/:49829967","doi":null,"is_oa":true,"landing_page_url":"https://nottingham-repository.worktribe.com/output/49829967","pdf_url":null,"source":{"id":"https://openalex.org/S4306402483","display_name":"Repository@Nottingham (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2984118562","https://openalex.org/W3111483071","https://openalex.org/W4249078870","https://openalex.org/W7169513554","https://openalex.org/W2979718521","https://openalex.org/W3096116713","https://openalex.org/W4417016100","https://openalex.org/W3104087958","https://openalex.org/W2607285804","https://openalex.org/W4300833949"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Sickle":[2,57],"cell":[3,13,58,390,920,924],"disease":[4,129,921],"(SCD)":[5],"is":[6,61,103,157,200,264,412,712],"an":[7,107,730,743,758,770,784,802,877,913],"inherited":[8],"group":[9],"of":[10,32,43,69,78,90,100,188,202,205,257,269,328,333,388,393,400,415,459,493,517,521,539,562,600,733,746,761,773,787,805,880,910],"red":[11],"blood":[12],"disorders":[14],"with":[15,41,106,123,144,159,272,279,296,385,417,495,512,519,608,695,706,918],"a":[16,85,98,160,233,386,455,496,699],"complex":[17],"pathophysiology":[18],"largely":[19],"driven":[20],"by":[21,373,448,620],"vaso-occlusion":[22,38],"and":[23,35,45,53,75,146,281,343,370,375,434,474,488,514,528,564,569,577,583,586,592,634,642,650,662,666,669,708,922],"hemolytic":[24],"anemia.":[25],"Vaso-occlusive":[26],"crises":[27],"(VOCs)":[28],"are":[29,39,177,305,378,664],"the":[30,62,88,110,203,243,258,267,308,413,440,444,449,477,491,515,635,648],"hallmark":[31],"SCD.":[33,93],"VOCs":[34],"continuing":[36],"silent":[37],"associated":[40,105,158],"cycles":[42],"inflammation":[44],"tissue":[46],"injury":[47,224,396],"that":[48,215,237],"can":[49,152,697],"lead":[50],"to":[51,65,182,209,221,239,265,289,299,315,470,484,533,616,689],"acute":[52,394],"chronic":[54,127],"organ":[55],"complications.":[56],"nephropathy":[59,925],"(SCN)":[60],"term":[63],"used":[64],"describe":[66],"kidney-related":[67],"complications":[68],"SCD;":[70,300],"manifestations":[71],"include":[72,383,463,560,622],"hyperfiltration,":[73],"albuminuria":[74,91,149,371],"progressive":[76],"loss":[77],"kidney":[79,128,135,275,395],"function.":[80],"Endothelial":[81],"dysfunction":[82],"may":[83,125],"play":[84],"role":[86],"in":[87,92,109,134,163,219,277,307,422,466,480,611,658,693,916],"development":[89],"Increased":[94],"plasma":[95],"endothelin-1":[96],"(ET-1),":[97],"biomarker":[99],"endothelial":[101],"dysfunction,":[102],"significantly":[104,241],"increase":[108],"urine":[111,543],"albumin-to-creatinine":[112],"ratio":[113,446,498],"(ACR)":[114],"(Ataga":[115,250],"et":[116,170,226,251],"al.":[117,171,227,252],"PLoS":[118],"One":[119],"2016).":[120],"Patients":[121],"(pts)":[122],"SCN":[124],"develop":[126,153],"(CKD;":[130],"diagnosed":[131],"when":[132],"abnormalities":[133],"structure":[136],"or":[137,347,363,403,503,735,748,763,775,789,807,882],"function":[138,276],"persist":[139],"for":[140,179,303,340,704,714],">3":[141],"mo).":[142],"Pts":[143,310,352],"SCD":[145,280,707],"baseline":[147],"(BL)":[148],"\u2265100":[150],"mg/g":[151],"persistent":[154],"albuminuria,":[155],"which":[156],"rapid":[161],"decline":[162,527],"estimated":[164,447],"glomerular":[165],"filtration":[166],"rate":[167,247],"(eGFR)":[168],"(Niss":[169],"Blood":[172,726,798],"Adv":[173],"2020).":[174],"No":[175],"treatments":[176],"approved":[178],"CKD":[180,297,358,522],"due":[181,298],"SCN;":[183],"current":[184],"SoC":[185,346,350],"usually":[186],"consists":[187],"angiotensin-converting":[189],"enzyme":[190],"inhibitors":[191],"(ACEI),":[192],"angiotensin-receptor":[193],"blockers":[194],"(ARBs)":[195],"and/or":[196],"hydroxyurea/hydroxycarbamide":[197],"(HU/HC).":[198],"P-selectin":[199,216,270],"one":[201],"drivers":[204],"multicellular":[206],"adhesion":[207],"leading":[208],"vaso-occlusion.":[210],"Preclinical":[211],"studies":[212],"have":[213,605,672],"shown":[214],"expression":[217],"increases":[218],"response":[220],"renal":[222,406,563,587],"ischemia-reperfusion":[223],"(Zizzi":[225],"J":[228],"Pediatr":[229],"Surg":[230],"1997).":[231],"Crizanlizumab,":[232],"humanized":[234],"monoclonal":[235],"antibody":[236],"binds":[238],"P-selectin,":[240,571],"reduced":[242],"median":[244],"annualized":[245],"VOC":[246],"vs":[248],"placebo":[249],"NEJM":[253],"2017).":[254],"The":[255,285,409,681,710,905],"aim":[256],"Phase":[259,682],"II":[260,683],"STEADFAST":[261,286,684],"study":[262,401,685],"(NCT04053764)":[263],"determine":[266],"effect":[268],"inhibition":[271],"crizanlizumab":[273,317,911],"on":[274,325,357,368,443,524,729,742,757,769,783,801,876],"pts":[278,292,301,384,416,494,518,604,705],"early-stage":[282],"CKD.":[283,709],"Methods:":[284],"trial":[287,711],"aims":[288],"enroll":[290],"148":[291],"aged":[293],"\u226516":[294],"yrs":[295],"eligible":[302],"inclusion":[304],"detailed":[306],"figure.":[309],"will":[311,353,437,451,551,907],"be":[312,354,438,452,552],"randomized":[313],"1:1":[314],"receive":[316],"5.0":[318],"mg/kg":[319],"(intravenous":[320],"infusion":[321],"over":[322],"30":[323],"min":[324],"Day":[326,331],"1":[327,332,341,717],"Wk":[329,334],"1,":[330],"3,":[335,471,485,574],"then":[336],"every":[337],"4":[338],"wks":[339],"yr)":[342],"their":[344,348],"usual":[345,349],"alone.":[351],"stratified":[355],"based":[356,367],"risk":[359,362],"category":[360],"(moderate":[361],"high/very":[364],"high":[365],"risk,":[366],"eGFR":[369,481,526],"assessed":[372],"ACR)":[374],"if":[376],"they":[377],"receiving":[379,405],"HU/HC.":[380],"Exclusion":[381],"criteria":[382],"history":[387],"stem":[389],"transplant,":[391],"evidence":[392],"within":[397],"3":[398,542],"mo":[399,510,585,594],"entry,":[402],"those":[404],"replacement":[407],"therapy.":[408],"primary":[410],"endpoint":[411],"proportion":[414,492,516],"\u226530%":[418],"decrease":[419],"from":[420,468,482,531],"BL":[421,469,483,513,532,582],"ACR":[423,467,529,540],"at":[424,454,508,554,572,581,589],"12":[425,475,489,509,534,578,584,593],"mo.":[426,535],"A":[427],"logistic":[428],"regression":[429],"model":[430],"including":[431,567],"treatment":[432],"effects":[433],"stratification":[435],"factors":[436],"utilized;":[439],"test":[441],"(based":[442,523],"log-odds":[445],"model)":[450],"performed":[453],"1-sided":[456],"significance":[457],"level":[458],"0.025.":[460],"Secondary":[461],"endpoints":[462,559],"mean":[464],"change":[465,479],"6,":[472,486,575],"9":[473,487,576],"mo,":[476,490,579],"percentage":[478],"protein-to-creatinine":[497],"(PCR)":[499],"improvement":[500],"(\u226520%":[501],"decrease)":[502],"stable":[504],"PCR":[505],"(within":[506],"\u00b120%)":[507],"compared":[511],"progression":[520],"pre-defined":[525],"increase)":[530],"To":[536],"minimize":[537],"variability":[538],"measurements,":[541],"samples":[544,546],"(2/3":[545],"collected":[547,553],"as":[548,676,912],"morning":[549],"voids)":[550],"all":[555],"designated":[556],"timepoints.":[557],"Exploratory":[558],"assessments":[561],"cardiac":[565],"biomarkers,":[566],"ET-1":[568],"soluble":[570],"BL,":[573,590],"echocardiography":[580],"MRI":[588],"6":[591],"(at":[595],"selected":[596],"sites).":[597],"Results:":[598],"As":[599],"July":[601],"2021,":[602],"31":[603],"been":[606,673,687],"enrolled,":[607],"36":[609],"sites":[610,619,638,645,657],"10":[612],"countries":[613],"currently":[614],"open":[615,713],"enrollment.":[617,715],"Open":[618],"country":[621],"USA":[623],"(9":[624],"sites),":[625,628,631],"Brazil":[626],"(5":[627],"Spain":[629],"(4":[630],"Italy,":[632],"Turkey":[633],"UK":[636],"(3":[637],"each),":[639,646],"France,":[640],"Greece":[641],"Panama":[643],"(2":[644],"Lebanon,":[647],"Netherlands":[649],"South":[651],"Africa":[652],"(1":[653],"site":[654],"each).":[655],"Study":[656],"Bahrain,":[659],"Egypt,":[660],"Ghana":[661],"Kenya":[663],"planned":[665],"Ireland,":[667],"Tanzania":[668],"Saudi":[670],"Arabia":[671],"recently":[674],"added":[675],"new":[677],"participating":[678],"countries.":[679],"Conclusion:":[680],"has":[686],"designed":[688],"evaluate":[690],"whether":[691],"crizanlizumab,":[692],"combination":[694],"SoC,":[696],"provide":[698],"potentially":[700],"targeted":[701],"disease-modifying":[702],"benefit":[703],"Figure":[716,718],"1.":[719],"Disclosures":[720],"Saraf:":[721],"Pfizer:":[722],"Research":[723,738,751,871,890,894,901],"Funding;":[724,739,872,891,895],"Global":[725,797],"Therapeutics:":[727,755,799,812],"Membership":[728,741,756,768,782,800,875],"entity's":[731,744,759,771,785,803,878],"Board":[732,745,760,772,786,804,879],"Directors":[734,747,762,774,788,806,881],"advisory":[736,749,764,776,790,808,883],"committees,":[737,750,884],"Novartis:":[740,781,814,831,844,873],"Funding.":[752,902],"Ataga:":[753],"Forma":[754],"committees;":[765,777,791],"Novo":[766],"Nordisk:":[767],"Agios":[778],"Pharmaceuticals:":[779,824,828],"Consultancy;":[780,796,813,815,817,832,852,854,861,863,868],"F.":[792,864],"Hoffmann-La":[793,865],"Roche":[794,866],"Ltd:":[795,867],"committees.":[809],"Derebail:":[810],"Travere":[811],"Bayer:":[816],"UpToDate:":[818],"Patents":[819],"&":[820],"Royalties.":[821],"Sharpe:":[822],"Napp":[823],"Speakers":[825],"Bureau;":[826],"Novartis":[827,838],"Consultancy.":[829,836],"Lebensburger:":[830],"Bio":[833],"Products":[834],"Laboratory:":[835],"DeBonnett:":[837],"Pharmaceuticals":[839],"Corporation:":[840],"Current":[841,845],"Employment.":[842,846],"Zhang:":[843],"Bartolucci:":[847],"INNOVHEM:":[848],"Other:":[849,857,885,898],"Co-founder;":[850],"Hemanext:":[851],"AGIOS:":[853],"Jazz":[855],"Pharma:":[856],"Lecture":[858,886,899],"fees;":[859],"GBT:":[860],"Emmaus:":[862],"Bluebird:":[869],"Consultancy,":[870,874,897],"fees,":[887,900],"Steering":[888],"committee,":[889],"Fabre":[892],"Foundation:":[893],"Addmedica:":[896],"OffLabel":[903],"Disclosure:":[904],"presentation":[906],"discuss":[908],"use":[909],"investigational":[914],"therapy":[915],"patients":[917],"sickle":[919,923]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-11-22T00:00:00"}